Amgen (AMGN) Tops Q2 EPS by 41c, Issues In-Line Guidance
Tweet
Share
E-mail_58cbc46cd3c33.jpg)
Get Alerts AMGN Hot Sheet
Price: $344.72 +2.11%
Revenue Growth %: +2.7%
Financial Fact:
Operating income: 2.53B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: +2.7%
Financial Fact:
Operating income: 2.53B
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Amgen (NASDAQ: AMGN) reported Q2 EPS of $4.25, $0.41 better than the analyst estimate of $3.84. Revenue for the quarter came in at $6.2 billion versus the consensus estimate of $6.18 billion.
GUIDANCE:
Amgen sees FY2020 EPS of $15.10-$15.75, versus the consensus of $15.64. Amgen sees FY2020 revenue of $25-25.6 billion, versus the consensus of $25.45 billion.
For earnings history and earnings-related data on Amgen (AMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AeroVironment restates quarterly financials, citing $89M goodwill error
- Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform
- C.H. Robinson acquires DeSpir Logistics for $75 million
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
